Paperpal Prime Logo

European Journal of Pharmaceutics and Biopharmaceutics : Impact Factor & More

eISSN: 1873-3441pISSN: 0939-6411

Aims and Scope of European Journal of Pharmaceutics and Biopharmaceutics

The European Journal of Pharmaceutics and Biopharmaceutics is a peer-reviewed medical journal and the official journal of the International Association for Pharmaceutical Technology. It publishes research on pharmaceutical technology, pharmaceutical biotechnology, and biopharmaceutics. Less

Key Metrics

CiteScore
9.7
Eigenfactor
0.01 - 0.05
Impact Factor
< 5
SJR
Q1Biotechnology
SNIP
1.21
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on European Journal of Pharmaceutics and Biopharmaceutics

European Journal of Pharmaceutics and Biopharmaceutics Journal Specifications

Overview
Publisher ELSEVIER
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1991
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in European Journal of Pharmaceutics and Biopharmaceutics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in European Journal of Pharmaceutics and Biopharmaceutics

Hyaluronic acid and PEA-based Rutin-loaded nanoparticles as new cardioprotective tool against anthracycline-induced cardiotoxicity.
  • 1 Sep 2026
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Site-specific enrichment of highly sialylated N-glycans in an erythropoietin-hybrid Fc fusion protein.
  • 1 Sep 2026
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Safety gaps in pediatric liquid antihypertensive compounding: a scoping review and regulatory-based safety assessment.
  • 1 Sep 2026
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Erratum to "'Site-specific enrichment of highly sialylated N-glycans in an erythropoietin-hybrid Fc fusion protein" [Eur. J. Pharm. Biopharm. 226 (2026) 115147
  • 1 Sep 2026
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
High-concentration biologic formulations: challenges, strategies, and emerging technologies for subcutaneous delivery.
  • 1 Sep 2026
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
A charge-reversible hyaluronic acid prodrug nanoplatform for synergistically enhanced tumor-targeted doxorubicin delivery.
  • 1 Sep 2026
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Hyaluronic acid and PEA-based Rutin-loaded nanoparticles as new cardioprotective tool against anthracycline-induced cardiotoxicity.
  • 1 Sep 2026
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Site-specific enrichment of highly sialylated N-glycans in an erythropoietin-hybrid Fc fusion protein.
  • 1 Sep 2026
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Safety gaps in pediatric liquid antihypertensive compounding: a scoping review and regulatory-based safety assessment.
  • 1 Sep 2026
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Erratum to "'Site-specific enrichment of highly sialylated N-glycans in an erythropoietin-hybrid Fc fusion protein" [Eur. J. Pharm. Biopharm. 226 (2026) 115147
  • 1 Sep 2026
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
High-concentration biologic formulations: challenges, strategies, and emerging technologies for subcutaneous delivery.
  • 1 Sep 2026
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
A charge-reversible hyaluronic acid prodrug nanoplatform for synergistically enhanced tumor-targeted doxorubicin delivery.
  • 1 Sep 2026
  • European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

FAQs on European Journal of Pharmaceutics and Biopharmaceutics